Author:
Michel Sophia,Linder Nicolas,Eggebrecht Tobias,Schaudinn Alexander,Blüher Matthias,Dietrich Arne,Denecke Timm,Busse Harald
Abstract
AbstractDifferent types of adipose tissue can be accurately localized and quantified by tomographic imaging techniques (MRI or CT). One common shortcoming for the abdominal subcutaneous adipose tissue (ASAT) of obese subjects is the technically restricted imaging field of view (FOV). This work derives equations for the conversion between six surrogate measures and fully segmented ASAT volume and discusses the predictive power of these image-based quantities. Clinical (gender, age, anthropometry) and MRI data (1.5 T, two-point Dixon sequence) of 193 overweight and obese patients (116 female, 77 male) from a single research center for obesity were analyzed retrospectively. Six surrogate measures of fully segmented ASAT volume (VASAT) were considered: two simple ASAT lengths, two partial areas (Ap-FH,Ap-ASIS) and two partial volumes (Vp-FH,Vp-ASIS) limited by either the femoral heads (FH) or the anterior superior iliac spine (ASIS). Least-squares regression between each measure andVASATprovided slope and intercept for the computation of estimated ASAT volumes (V~ASAT). Goodness of fit was evaluated by coefficient of determination (R2) and standard deviation of percent differences (sd%) betweenV~ASATandVASAT. Best agreement was observed for partial volumeVp-FH(sd% = 14.4% andR2 = 0.78), followed byVp-ASIS(sd% = 18.1% andR2 = 0.69) and AWFASIS(sd% = 23.9% andR2 = 0.54), with minor gender differences only. Other estimates from simple lengths and partial areas were moderate only (sd% > 23.0% andR2 < 0.50). Gender differences inR2generally ranged between 0.02 (dven) and 0.29 (Ap-FH). The common FOV restriction for MRI volumetry of ASAT in obese subjects can best be overcome by estimatingVASATfromVp-FHusing the equation derived here. The very simple AWFASIScan be used with reservation.
Publisher
Springer Science and Business Media LLC
Reference36 articles.
1. World Health Organization. The SuRF Report 2: Surveillance of Chronic Disease Risk Factors: Country-Level Data and Comparable Estimates (WHO, Geneva, 2005).
2. Hales, C. M. et al. Differences in obesity prevalence by demographic characteristics and urbanization level among adults in the United States, 2013–2016. JAMA 319(23), 2419. https://doi.org/10.1001/jama.2018.7270 (2018).
3. Flegal, K. M., Kit, B. K., Orpana, H. & Graubard, B. I. Association of all-cause mortality with overweight and obesity using standard body mass index categories: a systematic review and meta-analysis. JAMA 309(1), 71–82. https://doi.org/10.1001/jama.2012.113905 (2013).
4. Kitahara, C. M. et al. Association between class III obesity (BMI of 40–59 kg/m2) and mortality: a pooled analysis of 20 prospective studies. PLoS Med. 11(7), e1001673. https://doi.org/10.1371/journal.pmed.1001673 (2014).
5. Branca, F. et al. (eds) Die Herausforderung Adipositas und Strategien zu ihrer Bekämpfung in der Europäischen Region der WHO: Zusammenfassung (WHO Regionalbüro für Europa, Kopenhagen, 2007).
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献